Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-16

Clinical Trial Update: Reduction in the Occurrence of Center-Involved Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports a reduction in center-involved diabetic macular edema in patients with diabetic retinopathy; results were posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chromaderm, Inc. | Conditions: Diabetic Retinopathy | Phase 3 | Status: COMPLETED | Results posted: 2016-05-16